161 related articles for article (PubMed ID: 23231864)
1. Evaluation of fecal α1-proteinase inhibitor concentrations in cats with idiopathic inflammatory bowel disease and cats with gastrointestinal neoplasia.
Burke KF; Broussard JD; Ruaux CG; Suchodolski JS; Williams DA; Steiner JM
Vet J; 2013 May; 196(2):189-96. PubMed ID: 23231864
[TBL] [Abstract][Full Text] [Related]
2. Fecal alpha1-proteinase inhibitor concentration in dogs with chronic gastrointestinal disease.
Murphy KF; German AJ; Ruaux CG; Steiner JM; Williams DA; Hall EJ
Vet Clin Pathol; 2003; 32(2):67-72. PubMed ID: 12833220
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Bcl-2 apoptotic marker in cats diagnosed with inflammatory bowel disease and gastrointestinal lymphoma.
Swanson CM; Smedley RC; Saavedra PV; Kiupel M; Kitchell BE
J Feline Med Surg; 2012 Oct; 14(10):741-5. PubMed ID: 22710860
[TBL] [Abstract][Full Text] [Related]
4. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
[TBL] [Abstract][Full Text] [Related]
5. Serum cobalamin concentrations and small intestinal ultrasound changes in 75 cats with clinical signs of gastrointestinal disease: a retrospective study.
Jugan MC; August JR
J Feline Med Surg; 2017 Jan; 19(1):48-56. PubMed ID: 26239940
[TBL] [Abstract][Full Text] [Related]
6. Comparisons between cats with normal and increased fPLI concentrations in cats diagnosed with inflammatory bowel disease.
Bailey S; Benigni L; Eastwood J; Garden OA; McMahon L; Smith K; Steiner JM; Suchodolski JS; Allenspach K
J Small Anim Pract; 2010 Sep; 51(9):484-9. PubMed ID: 21050218
[TBL] [Abstract][Full Text] [Related]
7. Fecal S100A12 concentrations in cats with chronic enteropathies.
Zornow KA; Slovak JE; Lidbury JA; Suchodolski JS; Steiner JM
J Feline Med Surg; 2023 Mar; 25(3):1098612X231164273. PubMed ID: 36995216
[TBL] [Abstract][Full Text] [Related]
8. Fecal acute phase proteins in cats with chronic enteropathies.
Karra DA; Chadwick CC; Stavroulaki EM; Pitropaki MN; Flouraki E; Allenspach K; Lidbury JA; Steiner JM; Xenoulis PG
J Vet Intern Med; 2023; 37(5):1750-1759. PubMed ID: 37401847
[TBL] [Abstract][Full Text] [Related]
9. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
Becker K; Niederau C; Frieling T
Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
[TBL] [Abstract][Full Text] [Related]
10. Utility of endoscopic biopsies of the duodenum and ileum for diagnosis of inflammatory bowel disease and small cell lymphoma in cats.
Scott KD; Zoran DL; Mansell J; Norby B; Willard MD
J Vet Intern Med; 2011; 25(6):1253-7. PubMed ID: 22092613
[TBL] [Abstract][Full Text] [Related]
11. Histopathology and Feline Pancreatic Lipase Immunoreactivity in Inflammatory, Hyperplastic and Neoplastic Pancreatic Diseases in Cats.
Törner K; Staudacher M; Tress U; Weber CN; Stadler C; Grassinger JM; Müller E; Aupperle-Lellbach H
J Comp Pathol; 2020 Jan; 174():63-72. PubMed ID: 31955805
[TBL] [Abstract][Full Text] [Related]
12. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
[TBL] [Abstract][Full Text] [Related]
13. [Chronic-idiopathic enteropathy in cats--a case control study].
Meneses F; Ehinger B; Gerhardt A; Meyer-Lindenberg A; Hewicker-Trautwein M; Amtsberg G; Nolte I
Berl Munch Tierarztl Wochenschr; 2003; 116(7-8):340-5. PubMed ID: 12894691
[TBL] [Abstract][Full Text] [Related]
14. Feline small cell lymphosarcoma versus inflammatory bowel disease: diagnostic challenges.
Al-Ghazlat S; de Rezende CE; Ferreri J
Compend Contin Educ Vet; 2013 Jun; 35(6):E1-5; quiz E6. PubMed ID: 23677821
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Clinicopathological Features of Triaditis in a Prospective Case Series of Symptomatic and Asymptomatic Cats.
Fragkou FC; Adamama-Moraitou KK; Poutahidis T; Prassinos NN; Kritsepi-Konstantinou M; Xenoulis PG; Steiner JM; Lidbury JA; Suchodolski JS; Rallis TS
J Vet Intern Med; 2016 Jul; 30(4):1031-45. PubMed ID: 27296565
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
Chen CC; Huang JL; Chang CJ; Kong MS
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
18. Fecal alpha1-proteinase inhibitor concentration in dogs receiving long-term nonsteroidal anti-inflammatory drug therapy.
Murphy KF; German AJ; Ruaux CG; Steiner JM; Williams DA; Hall EJ
Vet Clin Pathol; 2003; 32(3):136-9. PubMed ID: 12966464
[TBL] [Abstract][Full Text] [Related]
19. Quantification of fecal alpha 1-antitrypsin excretion for assessment of inflammatory bowel diseases.
Becker K; Frieling T; Häussinger D
Eur J Med Res; 1998 Feb; 3(1-2):65-70. PubMed ID: 9512970
[TBL] [Abstract][Full Text] [Related]
20. Relationship between fecal lactoferrin and inflammatory bowel disease.
Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
